What does it mean to be immunocompromised?
UC infectious diseases expert featured in The New York Times
Even a seemingly minor threat like the common cold can lead to a serious illness in someone with a compromised immune system.
The Covid-19 pandemic made many people familiar with the term “immunocompromised.” But there is a broad spectrum of vulnerability, according to recent reporting in The New York Times.
Researchers have identified more than 430 so-called primary immunodeficiencies, rare conditions that are caused by genetic variants and weaken the immune system. Some of them can be detected through routine newborn screenings or other blood tests shortly after birth.
Certain chronic conditions such as multiple sclerosis, lupus, rheumatoid arthritis and AIDS can also leave people mildly immunocompromised. These diseases are often driven by an overactive immune system that starts damaging the body’s own cells, making it less capable of fighting off actual pathogens, said Carl Fichtenbaum, MD, infectious diseases professor in the Department of Internal Medicine at the University of Cincinnati College of Medicine.
He said some of these diseases are treated with high doses of steroids, which reduce inflammation but can weaken the immune system if taken for too long. Others are treated with biologic medicines, which target specific disease pathways that may indirectly affect the immune system.
Normal aging can also weaken the immune system in some ways. As people get older, they tend to produce fewer antibodies to fight off pathogens, and the defenses they do have may be deployed more slowly, said Dr. Fichtenbaum.
Click here to read the entire article in The New York Times.
Featured image at top: Person putting on disposable face mask. Photo/Unsplash.
Related Stories
What to know about lung adenocarcinoma following Pope Leo diagnosis
October 14, 2026
The University of Cincinnati Cancer Center's Robert Van Haren, MD, was featured in a Medical News Today article discussing the diagnosis, risk factors, symptoms and treatment of lung adenocarcinoma in light of Pope Leo XIV's recent diagnosis.
UC researchers help demonstrate proof-of-concept gene therapy for hydrocephalus
October 14, 2026
A proof-of-concept study led by UC’s Agnes (Yu) Luo, PhD, and collaborators at UC Davis shows that an adeno-associated virus (AAV) gene therapy can reduce hydrocephalus-associated tissue damage in animal models, pointing to a potential new treatment strategy.
How Ohio's political landscape has changed
October 13, 2026
UC Professor David Niven tells Spectrum News that Ohio has become a Republican stronghold after once serving as a bellwether for national elections.